Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
15.19
-2.43 (-13.79%)
At close: Mar 27, 2026, 4:00 PM EDT
16.97
+1.78 (11.69%)
After-hours: Mar 27, 2026, 7:10 PM EDT
Aktis Oncology Market Cap
Aktis Oncology has a market cap or net worth of $797.81 million as of March 27, 2026.
Market Cap
797.81M
Enterprise Value
563.46M
1-Year Change
n/a
Ranking
Category
Stock Price
$15.19
Market Cap Chart
Since the IPO on January 9, 2026, Aktis Oncology's market cap has decreased from $945.40M to $797.81M, a decrease of -15.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 925.44M | -5.47% |
| Mar 25, 2026 | 979.02M | 0.05% |
| Mar 24, 2026 | 978.49M | 2.48% |
| Mar 23, 2026 | 954.86M | 2.71% |
| Mar 20, 2026 | 929.64M | -1.56% |
| Mar 19, 2026 | 944.35M | -1.64% |
| Mar 18, 2026 | 960.11M | -4.94% |
| Mar 17, 2026 | 1.01B | -2.73% |
| Mar 16, 2026 | 1.04B | 4.11% |
| Mar 13, 2026 | 997.40M | 3.83% |
| Mar 12, 2026 | 960.63M | -5.77% |
| Mar 11, 2026 | 1.02B | 2.27% |
| Mar 10, 2026 | 996.87M | -0.42% |
| Mar 9, 2026 | 1.00B | 1.33% |
| Mar 6, 2026 | 987.94M | -8.42% |
| Mar 5, 2026 | 1.08B | -1.49% |
| Mar 4, 2026 | 1.10B | 3.12% |
| Mar 3, 2026 | 1.06B | 1.10% |
| Mar 2, 2026 | 1.05B | -0.65% |
| Feb 27, 2026 | 1.06B | 2.55% |
| Feb 26, 2026 | 1.03B | 0.67% |
| Feb 25, 2026 | 1.02B | -2.50% |
| Feb 24, 2026 | 1.05B | 2.93% |
| Feb 23, 2026 | 1.02B | 2.80% |
| Feb 20, 2026 | 992.67M | 2.66% |
| Feb 19, 2026 | 966.94M | 4.42% |
| Feb 18, 2026 | 925.97M | -1.78% |
| Feb 17, 2026 | 942.77M | 1.07% |
| Feb 13, 2026 | 932.80M | -0.78% |
| Feb 12, 2026 | 940.15M | -0.89% |
| Feb 11, 2026 | 948.55M | 1.46% |
| Feb 10, 2026 | 934.90M | -6.32% |
| Feb 9, 2026 | 997.92M | 0.11% |
| Feb 6, 2026 | 996.87M | -3.01% |
| Feb 5, 2026 | 1.03B | -1.76% |
| Feb 4, 2026 | 1.05B | -4.69% |
| Feb 3, 2026 | 1.10B | -4.91% |
| Feb 2, 2026 | 1.15B | 8.54% |
| Jan 30, 2026 | 1.06B | 3.11% |
| Jan 29, 2026 | 1.03B | -4.20% |
| Jan 28, 2026 | 1.08B | -3.39% |
| Jan 27, 2026 | 1.11B | -1.85% |
| Jan 26, 2026 | 1.14B | -0.14% |
| Jan 23, 2026 | 1.14B | -3.35% |
| Jan 22, 2026 | 1.18B | 9.80% |
| Jan 21, 2026 | 1.07B | 8.68% |
| Jan 20, 2026 | 985.84M | -4.96% |
| Jan 16, 2026 | 1.04B | -3.94% |
| Jan 15, 2026 | 1.08B | -1.20% |
| Jan 14, 2026 | 1.09B | -2.53% |
| Jan 13, 2026 | 1.12B | -1.84% |
| Jan 12, 2026 | 1.14B | 20.83% |
| Jan 9, 2026 | 945.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phathom Pharmaceuticals | 833.69M |
| MapLight Therapeutics | 820.61M |
| GH Research | 815.69M |
| Janux Therapeutics | 801.76M |
| ARS Pharmaceuticals | 801.33M |
| Evommune | 798.89M |
| Inventiva | 795.95M |
| SELLAS Life Sciences Group | 783.88M |